IMMIX BIOPHARMA ANNOUNCES PRICING OF UPSIZED $100 MILLION UNDERWRITTEN OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTS

Reuters · 1d ago

Please log in to view news